These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 18868576)

  • 41. Planned chemotherapy.
    FILDES P
    Ir J Med Sci; 1948 Oct; (274):659-67. PubMed ID: 18888587
    [No Abstract]   [Full Text] [Related]  

  • 42. Topotecan-based combination chemotherapy for human malignant glioma.
    Schmidt F; Schuster M; Streffer J; Schabet M; Weller M
    Anticancer Res; 1999; 19(2A):1217-21. PubMed ID: 10368678
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Synergy of chemotherapy and immunotherapy revealed by a genome-scale analysis of murine tuberculosis.
    Rodrigues RF; Zárate-Bladés CR; Rios WM; Soares LS; Souza PR; Brandão IT; Masson AP; Arnoldi FG; Ramos SG; Letourneur F; Jacques S; Cagnard N; Chiocchia G; Silva CL
    J Antimicrob Chemother; 2015; 70(6):1774-83. PubMed ID: 25687643
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas.
    An J; Sun Y; Fisher M; Rettig MB
    Leukemia; 2004 Oct; 18(10):1699-704. PubMed ID: 15343345
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chemotherapy in relation to dental extractions.
    PENINGTON GA
    Aust J Dent; 1947 Nov; 51(6):351-3. PubMed ID: 20272170
    [No Abstract]   [Full Text] [Related]  

  • 46. Recent advances in the chemotherapy of tuberculosis.
    RIGGINS HM
    N C Med J; 1947 Nov; 8(11):694-7. PubMed ID: 20271338
    [No Abstract]   [Full Text] [Related]  

  • 47. Energy mechanisms in malignant tumors in relation to chemotherapy.
    BLACK MM; KLEINER IS; BOLKER H
    Cancer Res; 1947 Dec; 7(12):818-26. PubMed ID: 18880698
    [No Abstract]   [Full Text] [Related]  

  • 48. Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo.
    Dicko A; Mayer LD; Tardi PG
    Expert Opin Drug Deliv; 2010 Dec; 7(12):1329-41. PubMed ID: 21118030
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antimetabolites.
    DANIEL LJ
    N Y State J Med; 1952 Sep; 52(18):2233-4. PubMed ID: 13002807
    [No Abstract]   [Full Text] [Related]  

  • 50. Factor associated with failure to administer subsequent treatment after progression in the first-line chemotherapy in EGFR-mutant non-small cell lung cancer: Okayama Lung Cancer Study Group experience.
    Kato Y; Hotta K; Takigawa N; Nogami N; Kozuki T; Sato A; Ichihara E; Kudo K; Oze I; Tabata M; Shinkai T; Tanimoto M; Kiura K
    Cancer Chemother Pharmacol; 2014 May; 73(5):943-50. PubMed ID: 24633759
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Facile preparation of doxorubicin-loaded upconversion@polydopamine nanoplatforms for simultaneous in vivo multimodality imaging and chemophotothermal synergistic therapy.
    Liu F; He X; Lei Z; Liu L; Zhang J; You H; Zhang H; Wang Z
    Adv Healthc Mater; 2015 Mar; 4(4):559-68. PubMed ID: 25471617
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Diabetes and tuberculosis within the framework of present chemotherapy and collapse therapy].
    VON KROGH GF
    Z Tuberk; 1953; 103(4-5):210-26. PubMed ID: 14374996
    [No Abstract]   [Full Text] [Related]  

  • 53. Current status of antimicrobial agents in pediatrics.
    KAGAN BM
    J Med Assoc Ga; 1955 May; 44(5):219-24. PubMed ID: 14368150
    [No Abstract]   [Full Text] [Related]  

  • 54. In vivo synergistic cytogenetic effects of aminophylline on lymphocyte cultures from patients with lung cancer undergoing chemotherapy.
    Mylonaki E; Manika K; Zarogoulidis P; Domvri K; Voutsas V; Zarogoulidis K; Mourelatos D
    Mutat Res; 2012 Dec; 740(1-2):1-5. PubMed ID: 23116732
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [The present efficacy of the chemotherapy of tuberculosis; report on the 15th meeting of the German Tuberculosis Society from 16 to 18 April in Wiesbaden].
    BRECKE F
    Hippokrates; 1953 Jun; 24(11):341-4. PubMed ID: 13084134
    [No Abstract]   [Full Text] [Related]  

  • 56. Combination chemotherapy of cancer based upon quantitative biochemical differences.
    SHAPIRO DM
    Surg Forum; 1955; 5():646-50. PubMed ID: 13247105
    [No Abstract]   [Full Text] [Related]  

  • 57. ["Efficacy Theory" may help to explain characteristic advantages of traditional Chinese medicines].
    Cai SQ; Wang X; Shang MY; Xu F; Liu GX
    Zhongguo Zhong Yao Za Zhi; 2015 Sep; 40(17):3435-43. PubMed ID: 26978986
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chemotherapy in veterinary medicine.
    HERDMAN NA; PAISLEY R
    Chem Drug Export Rev; 1948 Jul; 9(99):57-60. PubMed ID: 18874498
    [No Abstract]   [Full Text] [Related]  

  • 59. Do people believe combined hazards can present synergistic risks?
    Dawson IG; Johnson JE; Luke MA
    Risk Anal; 2012 May; 32(5):801-15. PubMed ID: 21992573
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bacterial chemotherapy.
    MOLITOR H
    Fed Proc; 1946 Jun; 5():304-12. PubMed ID: 20990891
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.